Biopharmaceutical Company Venture Capital Forum
|
|
Title: Practical Operations in Financing and Investment
Mr. Gang Yang, VP, VCChina
|
|
Title: New Start-up Opportunities in Promoting U.S./China Collaboration and Business
Dr. Mark Feitelson, Room 222 Alumni Hall, Dept of Pathology and Cell Biology, Thomas Jefferson University, USA
|
|
Title: Investment in Global Biotechnology Industry: Our Specialist Approach
Dr. Huaizheng PENG , MB, MM, Senior Portfolio Manager of Life Science and Technology, Reabourne Technology Investment Management Ltd, UK
|
|
Title: Consulting Services for Corporation Fund Raising
Mr. Tianping Wu , President, HK Wonderful Investment Group, ShangHai branch, China
|
|
Title: Challenges of Pharma Investing - An Investor's Perspective
Mr. Conrad Tsang , Principal, Baring Private Equity Asia Limited HK, China
|
|
Title: GQ-ODN T40214 as a Novel Anti-cancer Agent Targets Stat3 for Human Cancer Therapy
Dr. Naijie Jing , Associate Professor, Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, USA |
|
Title: China Pharmaceutical Technology Transfer Center
Dr. Xuemei Zhou , China Pharmaceutical Technology Transfer Center
|
|
Title: Universal Vaccine to the Control of Periodontal Disease
Dr. Xiaoju Shi , Adjunct Professor, Jiangsu University, China |
|
Title: Ntroduction of new Thrombolytic Drug 512
Dr. Gao Nannan , Institute of Materia Medica, Chinese Academy of Medical Sciences |
| |
Title: Anti-angiogenic Agents for Cancer Therapy
Dr. Ruian Xu, Institute of Molecular Medicine, Huaqiao University, China & Gene Therapy Laboratory, GRC, University of Hong Kong, Hong Kong, China |
| |
Title: Introduction of Oral Insulin Project
Dr. Hao Zhang , Naijing E-bayer Technology Co., Ltd. China |
|
Home
